147 related articles for article (PubMed ID: 36338681)
1. Polymorphic variants of
Martinelli M; Mancarella C; Scapoli L; Palmieri A; De Sanctis P; Ferrari C; Pasello M; Zucchini C; Scotlandi K
Front Oncol; 2022; 12():968884. PubMed ID: 36338681
[TBL] [Abstract][Full Text] [Related]
2. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis.
Mancarella C; Caldoni G; Ribolsi I; Parra A; Manara MC; Mercurio AM; Morrione A; Scotlandi K
Front Oncol; 2020; 10():994. PubMed ID: 32719743
[TBL] [Abstract][Full Text] [Related]
3. CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.
Martinelli M; Parra A; Scapoli L; De Sanctis P; Chiadini V; Hattinger C; Picci P; Zucchini C; Scotlandi K
Oncotarget; 2016 Nov; 7(47):77958-77967. PubMed ID: 27792997
[TBL] [Abstract][Full Text] [Related]
4. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy.
Mancarella C; Pasello M; Ventura S; Grilli A; Calzolari L; Toracchio L; Lollini PL; Donati DM; Picci P; Ferrari S; Scotlandi K
Clin Cancer Res; 2018 Aug; 24(15):3704-3716. PubMed ID: 29703820
[No Abstract] [Full Text] [Related]
5. Germline Variation and Somatic Alterations in Ewing Sarcoma.
Machiela MJ; Grünewald TGP
Methods Mol Biol; 2021; 2226():3-14. PubMed ID: 33326089
[TBL] [Abstract][Full Text] [Related]
6. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
[TBL] [Abstract][Full Text] [Related]
7. Migration/Differentiation-Associated LncRNA
Al Ageeli E; Attallah SM; Mohamed MH; Almars AI; Kattan SW; Toraih EA; Fawzy MS; Darwish MK
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360233
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.
Monument MJ; Johnson KM; McIlvaine E; Abegglen L; Watkins WS; Jorde LB; Womer RB; Beeler N; Monovich L; Lawlor ER; Bridge JA; Schiffman JD; Krailo MD; Randall RL; Lessnick SL
PLoS One; 2014; 9(8):e104378. PubMed ID: 25093581
[TBL] [Abstract][Full Text] [Related]
9. Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.
Lin SH; Sampson JN; Grünewald TGP; Surdez D; Reynaud S; Mirabeau O; Karlins E; Rubio RA; Zaidi S; Grossetête-Lalami S; Ballet S; Lapouble E; Laurence V; Michon J; Pierron G; Kovar H; Kontny U; González-Neira A; Alonso J; Patino-Garcia A; Corradini N; Bérard PM; Miller J; Freedman ND; Rothman N; Carter BD; Dagnall CL; Burdett L; Jones K; Manning M; Wyatt K; Zhou W; Yeager M; Cox DG; Hoover RN; Khan J; Armstrong GT; Leisenring WM; Bhatia S; Robison LL; Kulozik AE; Kriebel J; Meitinger T; Metzler M; Krumbholz M; Hartmann W; Strauch K; Kirchner T; Dirksen U; Mirabello L; Tucker MA; Tirode F; Morton LM; Chanock SJ; Delattre O; Machiela MJ
PLoS One; 2020; 15(9):e0237792. PubMed ID: 32881892
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
DuBois SG; Goldsby R; Segal M; Woo J; Copren K; Kane JP; Pullinger CR; Matthay KK; Witte J; Lessnick SL; Robison LL; Bhatia S; Strong LC
Pediatr Blood Cancer; 2012 Jul; 59(1):52-6. PubMed ID: 21793187
[TBL] [Abstract][Full Text] [Related]
11. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
12. Review: Ewing Sarcoma Predisposition.
Gargallo P; Yáñez Y; Juan A; Segura V; Balaguer J; Torres B; Oltra S; Castel V; Cañete A
Pathol Oncol Res; 2020 Oct; 26(4):2057-2066. PubMed ID: 31656020
[TBL] [Abstract][Full Text] [Related]
13. Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone.
Park H; Turkalo TK; Nelson K; Folmsbee SS; Robb C; Roper B; Azuma M
Cell Cycle; 2014; 13(15):2391-9. PubMed ID: 25483190
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical Interference of the EWS-FLI1-driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma.
Heisey DAR; Jacob S; Lochmann TL; Kurupi R; Ghotra MS; Calbert ML; Shende M; Maves YK; Koblinski JE; Dozmorov MG; Boikos SA; Benes CH; Faber AC
Mol Cancer Ther; 2021 Oct; 20(10):1868-1879. PubMed ID: 34315769
[TBL] [Abstract][Full Text] [Related]
15. EWS and RE1-Silencing Transcription Factor Inhibit Neuronal Phenotype Development and Oncogenic Transformation in Ewing Sarcoma.
Sankar S; Gomez NC; Bell R; Patel M; Davis IJ; Lessnick SL; Luo W
Genes Cancer; 2013 May; 4(5-6):213-23. PubMed ID: 24069508
[TBL] [Abstract][Full Text] [Related]
16. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
17. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
18. Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of
Mancarella C; Pasello M; Manara MC; Toracchio L; Sciandra EF; Picci P; Scotlandi K
Front Endocrinol (Lausanne); 2018; 9():178. PubMed ID: 29731738
[TBL] [Abstract][Full Text] [Related]
19. Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry.
Zöllner SK; Kauertz KL; Kaiser I; Kerkhoff M; Schaefer C; Tassius M; Jabar S; Jürgens H; Ladenstein R; Kühne T; Haveman LM; Paulussen M; Ranft A; Dirksen U
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497417
[TBL] [Abstract][Full Text] [Related]
20. Anti-Epileptic Drug Targets Ewing Sarcoma.
Kayarthodi S; Fujimura Y; Fang J; Morsalin S; Rao VN; Reddy ES
J Pharm Sci Pharmacol; 2014 Jun; 1(2):87-100. PubMed ID: 25664332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
